US Patent Issued to HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL on June 30 for "Benzimidazolone GLP-1 receptor agonist and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,587, issued on June 30, was assigned to HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL Co. LTD. (Zhejiang, China).

"Benzimidazolone GLP-1 receptor agonist and use thereof" was invented by Zhimin Zhang (Zhejiang, China), Zhe Wang (Zhejiang, China), Fang Tan (Zhejiang, China), Qian Wang (Zhejiang, China), Fan Hu (Zhejiang, China), Yan Xia (Zhejiang, China), Wenqiang Zhai (Zhejiang, China), Yuchen Zhang (Zhejiang, China), Jing Huang (Zhejiang, China) and Dongzhou Liu (Zhejiang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A benzimidazolone GLP-1 receptor agonist and the use thereof."

The patent was filed on Sept. 17, 2021, under Application No. 18/03...